We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Bulgarian Drug Agency (BDA) is responsible for oversight of clinical trials, which are subject to the Declaration of Helsinki, any relevant guidelines issued by the European Commission and the European Medicines Agency, and the principles of good clinical practice as defined in regulations issued by the Minister of Health.